We are live on ! Find out more
BBH icon

VanEck Biotech ETF
BBH

115 hedge funds and large institutions have $150M invested in VanEck Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

23% more first-time investments, than exits

New positions opened: 16 | Existing positions closed: 13

0% more funds holding

Funds holding: 115 → 115 (0)

1% less capital invested

Capital invested by funds: $152M → $150M (-$1.49M)

25% less repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 32

40.53% less ownership

Funds ownership: 78.34% → 37.81% (-41%)

Holders
115
Holders Change
–
Holders Change %
0%
% of All Funds
1.51%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
16
Increased
24
Reduced
32
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TWC
TD Waterhouse Canada
Ontario, Canada
+$10.7M
2
Bank of America
Bank of America
North Carolina
+$6.74M
3
Morgan Stanley
Morgan Stanley
New York
+$3.25M
4
ACA
Atlas Capital Advisors
Wyoming
+$959K
5
TAM
Tocqueville Asset Management
New York
+$922K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$2.7M
2
GT
Glenview Trust
Kentucky
-$1.65M
3
Jane Street
Jane Street
New York
-$1.48M
4
MIM
Miller Investment Management
Pennsylvania
-$1.28M
5
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management
Wisconsin
-$662K
Name Holding Trade Value Shares
Change 		Change in
Stake
AF
101
Allworth Financial
California
$19.4K – – –
FCMT
102
Founders Capital Management (Texas)
Texas
$15.7K – – –
WT
103
Whittier Trust
California
$15.7K – – –
FP
104
Financial Perspectives
Minnesota
$13.8K – – –
HWM
105
HighMark Wealth Management
Minnesota
$12.6K – – –
PS
106
Principal Securities
Iowa
$11.3K -$16.8K -100 -58%
HCM
107
Hollencrest Capital Management
California
$11K – – –
WIM
108
Westside Investment Management
California
$10.3K – – –
MG
109
Mather Group
Illinois
$7.95K +$168 +1 +2%
NA
110
NewEdge Advisors
Louisiana
$6.06K +$168 +1 +3%
CPA
111
Cardiff Park Advisors
California
$5.49K – – –
AIP
112
Ameritas Investment Partners
Nebraska
$4.71K – – –
National Bank of Canada
113
National Bank of Canada
Quebec, Canada
$3.92K -$8.41K -50 -67%
PP
114
Pacifica Partners
Canada
$3.92K – – –
Qube Research & Technologies (QRT)
115
Qube Research & Technologies (QRT)
United Kingdom
$3.77K – – –
IAIM
116
International Assets Investment Management
Florida
– -$11.1K -1,141,414 Closed
GT
117
Glenview Trust
Kentucky
– -$1.65M -9,300 Closed
Jane Street
118
Jane Street
New York
– -$1.48M -8,348 Closed
PWP
119
Pursue Wealth Partners
California
– -$532K -3,000 Closed
LFAS
120
Level Four Advisory Services
Texas
– -$368K -2,170 Closed
EH
121
Equitable Holdings
New York
– -$291K -1,638 Closed
Cambridge Investment Research Advisors
122
Cambridge Investment Research Advisors
Iowa
– -$276K -1,556 Closed
SFS
123
Strategic Financial Services
New York
– -$220K -1,238 Closed
SC
124
Scotia Capital
Ontario, Canada
– -$210K -1,186 Closed
PA
125
Parallel Advisors
California
– -$49.7K -280 Closed
2 3 4
5
6

BBH Hedge Fund Activity: Q4 2024 in Review

115 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2024, worth a combined $150M — down 0.98% from $152M a quarter earlier.

Buyers outnumbered sellers: 16 funds opened new BBH positions and 13 closed out — a net gain of 3 holders — while 24 added to existing stakes and 32 trimmed.

The largest buyer was TD Waterhouse Canada, opening a new position worth an estimated $10.7M. The largest seller was Citadel Advisors, cutting an estimated $2.7M.

  • 115 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2024, unchanged from Q3 2024.
  • Funds reported $150M of VanEck Biotech ETF stock for Q4 2024, down 0.98% quarter-over-quarter.
  • 16 funds opened new VanEck Biotech ETF positions in Q4 2024 and 13 closed out, a net change of +3 holders.
  • The largest VanEck Biotech ETF buyer in Q4 2024 was TD Waterhouse Canada, an estimated $10.7M added.
  • The largest VanEck Biotech ETF seller in Q4 2024 was Citadel Advisors, an estimated $2.7M sold.

Based on aggregated 13F filings for Q4 2024.